Shandong Realcan Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2024: -4.18%

Shandong Realcan Pharmaceutical Co Ltd (002589) has an Asset Resilience Ratio of -4.18% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 002589 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥-650.47 Million

≈ $-95.18 Million USD Cash + Short-term Investments

Total Assets

CN¥15.56 Billion

≈ $2.28 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2023)

This chart shows how Shandong Realcan Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See 002589 equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Shandong Realcan Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Shandong Realcan Pharmaceutical Co Ltd worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥-650.47 Million	-4.18%
Total Liquid Assets	CN¥-650.47 Million	-4.18%

Asset Resilience Insights

Limited Liquidity: Shandong Realcan Pharmaceutical Co Ltd maintains only -4.18% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Shandong Realcan Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shandong Realcan Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sigma Healthcare Ltd AU:SIG	Medical Distribution	0.03%
Jointown Pharmaceutical Group Co Ltd SHG:600998	Medical Distribution	0.08%
Arjo AB (publ) ST:ARJO-B	Medical Distribution	0.18%
Ebos Group Ltd AU:EBO	Medical Distribution	0.00%
Paragon Care Ltd AU:PGC	Medical Distribution	0.00%
Mayne Pharma Group Ltd AU:MYX	Medical Distribution	4.00%
Cyclopharm Ltd AU:CYC	Medical Distribution	1.98%
Profarma Distribuidora de Produtos Farmacêuticos S.A SA:PFRM3	Medical Distribution	4.48%

Annual Asset Resilience Ratio for Shandong Realcan Pharmaceutical Co Ltd (2015–2023)

The table below shows the annual Asset Resilience Ratio data for Shandong Realcan Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	-3.99%	CN¥-666.13 Million ≈ $-97.48 Million	CN¥16.71 Billion ≈ $2.45 Billion	+1.98pp
2022-12-31	-5.97%	CN¥-1.09 Billion ≈ $-160.10 Million	CN¥18.33 Billion ≈ $2.68 Billion	-3.05pp
2021-12-31	-2.92%	CN¥-770.06 Million ≈ $-112.68 Million	CN¥26.40 Billion ≈ $3.86 Billion	-3.05pp
2020-12-31	0.13%	CN¥40.79 Million ≈ $5.97 Million	CN¥31.29 Billion ≈ $4.58 Billion	-0.48pp
2019-12-31	0.61%	CN¥198.09 Million ≈ $28.99 Million	CN¥32.47 Billion ≈ $4.75 Billion	+0.39pp
2018-12-31	0.22%	CN¥77.83 Million ≈ $11.39 Million	CN¥34.84 Billion ≈ $5.10 Billion	+0.21pp
2017-12-31	0.01%	CN¥2.54 Million ≈ $371.80K	CN¥26.98 Billion ≈ $3.95 Billion	+0.08pp
2016-12-31	-0.07%	CN¥-11.55 Million ≈ $-1.69 Million	CN¥15.66 Billion ≈ $2.29 Billion	+0.00pp
2015-12-31	-0.08%	CN¥-6.91 Million ≈ $-1.01 Million	CN¥8.86 Billion ≈ $1.30 Billion	--

pp = percentage points

About Shandong Realcan Pharmaceutical Co Ltd

SHE:002589 China Medical Distribution

Market Cap

$592.30 Million

CN¥4.05 Billion CNY

Market Cap Rank

#11560 Global

#3336 in China

Share Price

CN¥2.69

Change (1 day)

-1.10%

52-Week Range

CN¥2.64 - CN¥4.69

All Time High

CN¥17.35